Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...
Johnson & Johnson (NYSE:JNJ) reported results from the randomized STEMI DTU trial of its Impella CP device at ACC 2026. The ...
In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.
Artificial intelligence (AI)-based algorithms that use electrocardiogram (ECG) data have high accuracy in predicting ...
News from ACC 2026 dominates our most-read list, along with the dyslipidemia guidelines, Lp(a) vs CAC, and apixaban for VTE.
MedPage Today on MSN
Impella flops for acute coronary syndrome patients not in shock
Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...
A combination of left ventricular support plus delayed percutaneous coronary intervention did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock, ...
Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.
Mondays seem to be bad for your heart, according to new research from the British Heart Foundation. The most dangerous type of heart attack, known as a STEMI, is more likely to occur on a Monday than ...
A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results